(redirected from reticuloendothelial system)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Related to reticuloendothelial system: reticuloendothelial cells


[Latin, A thing.] An object, a subject matter, or a status against which legal proceedings have been instituted.

For example, in a suit involving a captured ship, the seized vessel is the res, and proceedings of this nature are said to be in rem. Res, however, does not always refer to tangible Personal Property. In matrimonial actions, for example, the res is the marital status of the parties.

West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.


(rayz) n. Latin, thing. In law lingo res is used in conjunction with other Latin words as "thing that."

Copyright © 1981-2005 by Gerald N. Hill and Kathleen T. Hill. All Right reserved.

Res, generalem habet significationem, quia tam corporea, quam incorporea, cujuscunque sunt generis, naturae sive speciei, comprehendit. The word things has a general signification, which comprehends corporeal and incorporeal objects, of whatever nature, sort or specie. 3 Co. Inst. 482; 1 Bouv. Inst. n. 415.

RES, property. Things. The terms "Res," "Bona," "Biens," used by jurists who have written in the Latin and French languages, are intended to include movable or personal, as well as immovable or real property. 1 Burge, Confl. of Laws, 19. See Biens; Bona; Things.

A Law Dictionary, Adapted to the Constitution and Laws of the United States. By John Bouvier. Published 1856.
References in periodicals archive ?
Therefore, polymeric micelle whose surface is covered with poly(Sar) was also expected to show a prolonged blood circulation behavior with low undesired accumulation by reticuloendothelial system (RES).
capsulatum (the American form) mainly causes pulmonary involvement resembling tuberculosis and may pass asymptomatically to involve the reticuloendothelial system and the skin.
Surface opsonisation promotes the removal of particles from the circulation within seconds to minutes through the mononuclear phagocytic system (MPS), also known as reticuloendothelial system (RES), and by Kupffer cells, phagocytic macrophages permanently located in the liver [4].
Visceral leishmaniasis (VL) is vector borne parasitic disease which results from the infection of macrophages in reticuloendothelial system associated with immunoinflammatory response [1].The higher altitudes negatively affect the distribution of vector, and therefore leishmaniasis is considered to be almost absent in highlands [2].
Hemolysis is classified as either intravascular, occurring within the blood vessels, or extravascular, mediated by phagocytic destruction in the reticuloendothelial system. Recognizing hemolysis requires a careful review of clinical history, signs, symptoms, and laboratory test results.
These include hemodilulation9, foot strike hemolysis, iron losses in feces, urine, sweat, decrease iron absorption, a shift in red-cell catabolism from the reticuloendothelial system to the hepatocytes, and increased skeleton myoglobin.
The reticuloendothelial system of the spleen and kidney were particularly observed to phagocytose the injected colloidal carbon indicating that they are the main organs of immune response in catfish.
Even if the reaction is not severe, delayed haemolysis in the extravascular reticuloendothelial system can cause renal failure, acute coronary syndrome and coagulation failure.
Critical are the dimension of the nanoparticle (it should be large enough to avoid leaking into healthy blood vessels but small enough to pass through the highly permeable, abnormal vasculature associated with tumors) and its surface (it should be hydrophilic to help avoid rapid uptake by the reticuloendothelial system).
Method to increase blood half-lives of nanoparticles that are otherwise foreign to the body includes PEGylation that avoids fast removal by the reticuloendothelial system. This allows larger amount of injected material to reach and bind the desired sites.
Hemophagocytosis in the bone marrow or reticuloendothelial system including liver, spleen and lymph nodes was reported to be detected in one-half or two-thirds of the patients with HLH, so hemophagocytosis may not always be observed in the bone marrow aspiration, especially at the disease onset.